80230 Drug assay infliximab
Pathology & Lab
Also known as: infliximab level, Remicade level
Laboratory quantitative drug assay for infliximab to assess serum level and antibodies for therapeutic drug monitoring in inflammatory disease treatment.
Clinical Context
Monitors tumor necrosis factor-alpha inhibitor levels and anti-drug antibodies in inflammatory bowel disease and rheumatoid arthritis for optimal therapeutic response.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.